Skip to main content
CLX
NYSE Manufacturing

Clorox Names Unilever Executive Fabian Garcia CEO, Effective January 2027

Tom Rudovsky · Reported by PR Newswire
More coverage: Household Product Stocks · Consumer
Sentiment info
Neutral
Importance info
7
Price
$88
Mkt Cap
$10.502B
52W Low
$79.12
52W High
$128.9
52W Position info
11% above low
Off High info
32% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CLX is trading near its 52-week low of $79.12 (11% above the low).

Summary

Clorox named Fabian Garcia, currently president of Unilever Personal Care, as chief executive effective January 5, 2027, with the board appointing him to the CEO role and board on October 28, 2026 under an offer letter dated October 27, 2026. He succeeds Linda Rendle, who announced in May she would step down for health reasons and steps down as CEO, chair and board member effective January 5, 2027; her transition is a Retirement under her outstanding long-term incentive awards, which vest on their original terms, and she will not receive additional long-term or incentive equity awards during her advisory period through April 2, 2027, when her current base salary of $1,350,000 remains in effect. Garcia brings four decades in consumer products, including CEO of Revlon and senior roles at Colgate-Palmolive and P&G, and will not receive additional compensation for serving as a director. His offer letter sets a $100,000 base salary, a $2M target bonus settled in company stock and prorated for fiscal 2027, a $4.55M pro-rated long-term award split 60% performance share units vesting after the fiscal 2027-2029 performance period and 40% RSUs vesting ratably over four years, a $9.1M annual long-term target from 2027 in performance share units and RSUs vesting ratably over four years, and an $11M sign-on RSU award vesting over three years that vests in full on an involuntary termination without Cause or with Good Reason under the Third Amended and Restated Executive Change in Control Severance Plan; salary-related benefits use a peer median salary initially set at $1,250,000 and reviewed annually. Lead independent director Matthew Shattock becomes independent chair at the same time, receiving a $225,000 Independent Chair retainer in addition to the annual director retainer and annual grant of deferred stock units. The appointment closes out the succession flagged in the FY26 10-K, which also disclosed debt doubling to $5.1B after the GOJO acquisition and a 26% drop in EPS — Garcia inherits a leveraged balance sheet and weak organic sales. Q1 FY27 results are due Monday, Nov. 2, with Rendle and CFO Luc Bellet hosting the call.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — Garcia's offer letter sets a $100,000 base salary, $2M target bonus, $4.55M pro-rated long-term award, $9.1M annual long-term target from 2027 and an $11M sign-on RSU award vesting over three years.

    • Garcia Pay Package
      • Garcia's $2,000,000 target annual bonus is settled in shares of Company common stock and prorated for fiscal year 2027.
      • Garcia's $4,550,000 pro-rated long-term award is 60% performance share units vesting after the fiscal 2027–2029 performance period and 40% RSUs vesting ratably over four years.
      • From September 2027, Garcia's annual long-term award with a target value of $9,100,000 is comprised of performance share units and RSUs vesting ratably over four years.
    • Sign-On Vesting — Garcia's sign-on RSUs vest in full on an involuntary termination without 'Cause' or with 'Good Reason' under the Third Amended and Restated Executive Change in Control Severance Plan.
    • Rendle Advisory Terms — Rendle's current base salary of $1,350,000 remains in effect during the advisory period through April 2, 2027. She will not receive any additional long-term or incentive equity awards during the advisory period, and her transition is a 'Retirement' under her outstanding long-term incentive awards, which vest in accordance with their original terms.
    • Chair Compensation — Shattock receives an Independent Chair retainer of $225,000 in addition to the annual director retainer and annual grant of deferred stock units.
    • Benefits Benchmark — Salary-related benefits and perquisites use a peer median salary, initially set at $1,250,000, reviewed annually.
    • Appointment Dates — The board appointed Garcia as CEO and board member on October 28, 2026, with an offer letter dated October 27, 2026. Rendle steps down as CEO, Chair and board member effective January 5, 2027, when the board approved the terms of her advisory arrangement.
    • Director Pay — Garcia will not receive additional compensation for his service as a director of the Company.
    All 14 details
    • Shattock receives an Independent Chair retainer of $225,000 in addition to the annual director retainer and annual grant of deferred stock units.
    • Salary-related benefits and perquisites use a peer median salary, initially set at $1,250,000, reviewed annually.
    • Rendle's current base salary of $1,350,000 remains in effect during the advisory period through April 2, 2027.
    • Rendle's transition is a 'Retirement' under her outstanding long-term incentive awards, which vest in accordance with their original terms.
    • Rendle will not receive any additional long-term or incentive equity awards during the advisory period.
    • Garcia's sign-on RSUs vest in full on an involuntary termination without 'Cause' or with 'Good Reason' under the Third Amended and Restated Executive Change in Control Severance Plan.
    • Garcia's $4,550,000 pro-rated long-term award is 60% performance share units vesting after the fiscal 2027–2029 performance period and 40% RSUs vesting ratably over four years.
    • From September 2027, Garcia's annual long-term award with a target value of $9,100,000 is comprised of performance share units and RSUs vesting ratably over four years.
    • Garcia's $2,000,000 target annual bonus is settled in shares of Company common stock and prorated for fiscal year 2027.
    • Board appointed Fabian Garcia as CEO and Board member on October 28, 2026; offer letter dated October 27, 2026.
    • Linda Rendle steps down as CEO, Chair and Board member effective January 5, 2027.
    • Mr. Garcia will not receive additional compensation for his service as a director of the Company.
    • Mr. Garcia has no familial relationships nor related party transactions with the Company requiring disclosure under Items 401(d) or 404(a) of Regulation S-K.
    • On January 5, 2027, the Board approved the terms of Rendle's Advisory Arrangement.

At the time of this announcement, CLX was trading at $88.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $10.5B. The 52-week trading range was $79.12 to $128.90. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

CLX - Latest Insights

CLX
Nov 02, 2026, 4:45 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $92.00
Real-time Price: $106.11 info
Change: +$14.11 (+15%) info
Market Cap: $12.832B info
CLX
Nov 02, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $94.25
Real-time Price: $106.11 info
Change: +$11.86 (+13%) info
Market Cap: $12.832B info
CLX
Nov 02, 2026, 4:10 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $88.37
Real-time Price: $106.11 info
Change: +$17.74 (+20%) info
Market Cap: $12.832B info
CLX
Aug 07, 2026, 4:15 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $105.20
Real-time Price: $106.11 info
Change: +$0.910 (+0.87%) info
Market Cap: $12.832B info
CLX
Aug 03, 2026, 7:42 PM EDT
Source: Binance News
Importance Score:
7
Price at Filing: $98.63
Real-time Price: $106.11 info
Change: +$7.48 (+8%) info
Market Cap: $12.832B info